Anzeige
Mehr »
Login
Mittwoch, 22.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Wachstumsgeschichte: Analysten sehen kurzfristige +37 %-Chance bei diesem europäischen Marktführer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
147 Leser
Artikel bewerten:
(0)

MedQuist Awarded Computer-Assisted Coding and Services Contract for Cooper

FRANKLIN, Tenn., April 13, 2011 /PRNewswire/ -- MedQuist Holdings Inc. , a leading provider of medical transcription services and technology-enabled clinical documentation workflow solutions, today announced that it has been awarded a contract by Cooper University Hospital in Camden, New Jersey, a leading academic medical center, to provide computer-assisted coding technology and outsourced coding services.

Cooper selected MedQuist based on its ability to demonstrate both ICD-10 readiness as well as the streamlined workflow features built in to the CodeRunner(TM)CAC technology platform - including automatic chart assignment and automatic quality assurance - which enable complete, accurate coding in a rapid, efficient manner. The addition of outsourced coding services expands Cooper's current partnership with MedQuist for transcription outsourcing services.

MedQuist's transcription solutions feed clinical documents directly into CodeRunner(TM)CAC - speeding the coding process and helping providers to obtain reimbursement faster.

"After partnering with MedQuist to help manage our speech recognition and transcription needs and seeing CodeRunner(TM)CAC in action, it was clear that MedQuist has the optimal mix of advanced technology, coding expertise, and knowledgeable staff to help us be completely prepared for ICD-10 as well as meet today's challenges of rising coding volumes and coder shortages," stated Marti Heesen-May, director of Health Information Management for Cooper.

"We are proud to partner with such a prestigious organization and are honored that Cooper has chosen to expand its partnership with MedQuist to include coding technology and services," says Maryagnes Marek, vice president of Coding and HIM Compliance at MedQuist. "This agreement demonstrates that MedQuist is the vendor of choice to speed revenue cycles, reduce denials and meet the complexity of the expanded code sets that ICD-10 will bring in 2013."

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabledclinical documentation workflow. MedQuist's enterprisesolutions - including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors - help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

About Cooper University Hospital

Cooper University Hospital is the flagship of The Cooper Health System. It is the premier university hospital serving South Jersey and the Delaware Valley. Currently the core clinical campus for the Robert Wood Johnson Medical School in Camden, Cooper recently announced plans to expand its role as a leader in medical education and research with the creation of the Cooper Medical School of Rowan University. This four-year allopathic medical school in partnership with Rowan University will seat its first class in 2012. Cooper is renowned for Signature Programs in cardiology, cancer, critical care, trauma, orthopedics and neurology. Cooper is in the midst of a $600 million expansion of its Camden Health Sciences Campus - including a new $220 million patient Pavilion which opened in 2008. Cooper continues its regional expansion with the opening of new and expanded facilities throughout Camden, Burlington and Gloucester Counties.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

MedQuist Holdings Inc.

CONTACT: Katie Weaver, Marketing Communications, +1-267-940-5765,
kweaver@medquist.com

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.